Angelman Syndrome due to familial translocation: unexpected additional results characterized by Microarray-based Comparative Genomic Hybridization
© Yokoyama-Rebollar et al.; licensee BioMed Central. 2015
Received: 22 December 2014
Accepted: 16 March 2015
Published: 9 April 2015
The 15q11q13 region is subject to imprinting and is involved in various structural rearrangements. Less than 1% of Angelman Syndrome patients are due to translocations involving 15q11q13. These translocations can arise de novo or result from the segregation of chromosomes involved in a familial balanced translocation.
A 5-year-old Mexican girl presented with developmental delay, minor dysmorphic features and history of exotropia. G-banding chromosome analysis established the diagnosis of Angelman Syndrome resulting from a familial translocation t(10;15) involving the 15q11.2 region. The available family members were studied using banding and molecular cytogenetic techniques, including Microarray-based Comparative Genomic Hybridization, which revealed additional unexpected results: a coincidental and smaller 15q deletion, asymptomatic duplications in 15q11.2 and Xp22.31 regions.
This report demonstrates the usefulness of array CGH for a detailed characterization of familial translocations, including the detection of submicroscopic copy number variations, which would otherwise be missed by karyotype analysis alone. Our report also expands two molecularly characterized rare patient cohorts: Angelman Syndrome patients due to familial translocations and patients with 15q11.2 duplications of paternal origin.
KeywordsAngelman Syndrome Translocation 15q11.2 array CGH
Low copy repeats (LCRs) in proximal 15q facilitate recombination events; hence, they are frequently involved in chromosomal structural rearrangements . The 15q11q13 region contains several imprinted genes, such as UBE3A, whose de novo deletion in the maternal allele causes approximately 70% of Angelman Syndrome (AS) patients and the loss of paternal allele causes Prader-Willi Syndrome (PWS) .
On the other hand, unbalanced translocations account for less than 1% of AS patients; these translocations may result from segregation of chromosomes involved in a familial balanced translocation . With the advent of new molecular techniques such as microarray-based Comparative Genomic Hybridization (array CGH), these unbalanced rearrangements can be fully characterized. Furthermore, unexpected chromosomal imbalances have been observed when analyzing complex familial rearrangements, which might affect the phenotype of the involved family members [4,5].
In this report, we present the clinical, cytogenetic and molecular findings of a Mexican patient who fulfills diagnostic criteria established for AS , as a result of 3:1 segregation of a familial (10;15) translocation involving 15q11.2. Unexpected additional findings by aCGH in three family members are described in detail.
She was referred to our Medical Genetics service for evaluation because of global developmental delay and a history of exotropia. On physical examination, the weight and height were between the 25th and 50th centile, and the head circumference was in the 10th centile. The patient exhibited slight brachycephaly, low anterior hair implantation, bushy eyebrows, bilateral epicanthal folds, telecanthus, slightly broad nasal bridge, prominent nose with a bulbous tip, short, broad and smooth philtrum, wide mouth, lips with an absent Cupid’s bow, intact palate and uvula, normal pinnae, chest with widely spaced nipples, hands with tapered fingers, broad thumbs and broad 2nd fingers (Figure 1B).
Our patient was considered to have moderate intellectual disability with deficits in all adaptive functions but her language skills were the most affected. At the age of 5, she remained without bowel control and could not run or jump. She climbed stairs with support and only spoke 4 disyllables. In addition, food aversion, excessive salivation, water attraction, fascination with objects that crinkle and squeak (such as certain papers and plastics), constipation and a history of sleep disturbance were also noticed. Her MRI showed mild cortical and subcortical brain atrophy, and her EEG demonstrated paroxysmal activity in the left and right occipital region, which did not generate abnormal movements. While awake, she exhibited multiple movements in both hands that were unrelated to paroxysmal activity.
Array CGH results in the five available members family
Furthermore, banding karyotype in maternal uncle (II-3) and his daughter (III-2) showed a small supernumerary marker chromosome (sSMC) derived from chromosome 15, [47,+der(15)t(10;15)(q26.3;q11.2)] which resulted from a 3:1 segregation of the familial translocation, that consequently led to a partial 15q and partial 10q trisomy. The uncle had a wide nasal base and a wide philtrum, but was otherwise healthy and had normal intelligence. His daughter had a depressed nasal bridge, anteverted nares and tented upper lip vermilion; she reached the expected milestones at 6 months. When the array CGH was performed, they showed a 2.8 Mb partial trisomy 15 in II-3 and a larger 5.1 Mb partial trisomy in his daughter [15q11.2(22,784,523-25,582,821) vs. 15q11.1q11.2(20,481,702-25,582,821)] (Table 1; Figure 5).
Cases of Angelman syndrome resulting from familial translocations are rare (less than 1%) . Due to imprinting, the family described in the present report is at risk for two different neurogenetic disorders, AS and PWS, which are rarely seen together in the same kindred [7,8]. The proband in this family has a 5 Mb partial monosomy of the 15pterq11.2 region and a 1 Mb partial monosomy of 10q26.3qter as a result of 3:1 segregation of a familial translocation (10;15), which is the most frequently observed when an acrocentric chromosome is involved [9,10]. The partial deletion in our patient at chromosome 15 is of maternal origin, and was proved to include the UBE3A gene leading to the diagnosis of AS .
When she was evaluated, some of her features were not in accordance with classical AS patients, because her developmental delay was functionally moderate and not severe, in addition she did not have marked ataxia or laughter. Yet, she fulfilled the diagnostic criteria for AS given that she exhibited unsteadiness and clumsiness, speech impairment with minimal use of words, and the EEG abnormalities among other features already described . Partial monosomy of distal 10q has been associated with craniofacial, cardiac, and urogenital defects, as well as with neuropsychiatric disorders ; however, the deletion in our patient is distal to the critical region for this phenotype. Therefore, we can attribute the proband’s phenotype to partial 15q monosomy.
The region involved in the maternal uncle (II-3) and his daughter (III-2) is outside from the critical region described in the10q distal trisomy syndrome. This led us to expect them to have a normal phenotype . It is important to point out that their triple dose of 15q11q11.2 is of paternal origin, when most of the reports with abnormal phenotype due to a sSMC involving the critical region for PWS/AS, are primarily of maternal origin . Michelson et al. described a carrier of a 15-derived supernumerary chromosome of maternal origin. This patient had macrocephaly, ventricular dilatation, hypotonia, epilepsy and intellectual disability . Other reports of 15q11q13 trisomy or tetrasomy have attributed the phenotype to the maternally expressed genes dosage including UBE3A, as well as to the non-imprinted genes, such as GABA receptor subunit gene, which are involved in epileptogenesis [16-18]. There are few reports of interstitial 15q11q13 paternal origin duplications associated with abnormal phenotypes [19,20].
The 15q11.1q11.2 2 Mb-deleted region in the grandfather (I-1) and maternal uncle (II-3) contains only 15 genes, of which 10 are non-coding RNAs, 3 are mRNA with unknown function and 2 encode for olfactory receptors; therefore we believe that this microdeletion does not alter their phenotype. It is important to recall that the 15q11q13 region is flanked by 5 breakpoints (BPs), and typical AS/PWS deletions have BP1 or BP2 as the proximal breakpoint and BP3 as the distal breakpoint. Recently, a microdeletion between BP1 and BP2 has been associated to different phenotypes [21-24]; however, after conducting research of published reports and databases such as DECIPHER, we did not find any patient reported to have the same distal imbalance proximal to BP1 as the grandfather has (I-1).
Regarding the 1.56 Mb microduplication of the Xp22.31 region observed in the proband’s cousin (III-2), there have been at least 35 patients described with this same duplication, its pathogenicity remains controversial . A previous study reported the prevalence of the microduplication to be 0.15% in healthy individuals and 0.37% in patients with intellectual disability or behavioral disturbances, suggesting a modifier or risk factor for disease; however, this result was not statistically significant . Another study also indicated that this condition might predispose to an abnormal phenotype; nevertheless, the authors stated that additional genomic changes are required .
Reports of familial translocations involving 15q11q13 [7,14,28-34] including ours, have shown the importance of karyotype analysis as part of the diagnostic approach in PWS and AS patients, especially in those where the phenotype is not classical. This analysis should be performed in order to search for underestimated structural chromosomal rearrangements that could be inherited, with important implications in the recurrence risk and the possibility of prenatal diagnosis [7,35]. In fact, some diagnostic algorithms for PWS/AS already include the use of karyotype .
The present report is another example of the importance of molecular characterization using array CGH in familial translocations to accurately define genomic imbalances for each family member, as well as for detection of submicroscopic copy number variations, which would otherwise be missed by karyotyping alone. The detailed clinical, cytogenetic and molecular characterization also contributes to pursue a genotype phenotype correlation.
G-banding cytogenetic studies were performed from peripheral blood lymphocytes by standard method of GTG banding technique (Giemsa). Subsequently, genomic DNA was obtained from all family members in whom karyotype revealed a translocation (10;15) or the presence of any derivative of this rearrangement. Whole-genome array CGH analysis was performed using 500 ng of genomic DNA and a 60 K oligonucleotide array (Agilent Technologies, Santa Clara, CA, USA; design G4450A) according to protocols provided by the manufacturer. Image quantification, hybridization quality control and copy number variants (CNVs) detection were performed using Agilent Feature Extraction v11.5 and Agilent Workbench v7.0. CNVs identified in the samples were visualized using the UCSC Genome Browser website (http://genome.ucsc.edu) and compared to the Database of Genomic Variants (http://projects.tcag.ca/variation) to exclude copy number changes considered to be benign variants. The DECIPHER (Database of Chromosomal Imbalance and Phenotype in Humans using Ensembl Resources) (https://decipher.sanger.ac.uk/) and ECARUCA (European Cytogeneticists Association Register of Unbalanced Chromosome Aberrations) (http://umcecaruca01.extern.umcn.nl:8080/ecaruca/ecaruca.jsp) databases were used as resources to aid in the genotype-phenotype correlation. Validation of variants detected by array CGH was performed by fluorescence in situ hybridization (FISH) using Kreatech probes (http://www.kreatech.com/) with the standard methodology.
Written informed consent was obtained from the patient’s parents for publication and accompanying images of this case report. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Federal Founds 2015/INP and CONACYT (CONACYT-SALUD-87792) for their financial support.
- Pujana MA, Nadal M, Guitart M, Armengol L, Gratacos M, Estivill X. Human chromosome 15q11-q14 regions of rearrangements contain clusters of LCR15 duplicons. Eur J Hum Genet. 2002;10:26–35.View ArticlePubMedGoogle Scholar
- Horsthemke B, Wagstaff J. Mechanisms of imprinting of the Prader-Willi/Angelman region. Am J Med Genet A. 2008;146A:2041–52.View ArticlePubMedGoogle Scholar
- Jiang Y, Lev-Lehman E, Bressler J, Tsai TF, Beaudet AL. Genetics of Angelman syndrome. Am J Hum Genet. 1999;65:1–6.View ArticlePubMed CentralPubMedGoogle Scholar
- Fauth C, Gribble SM, Porter KM, Codina-Pascual M, Ng BL, Kraus J. Micro-array analyses decipher exceptional complex familial chromosomal rearrangement. Hum Genet. 2006;119(1–2):145–53.View ArticlePubMedGoogle Scholar
- Bartsch O, Vlcková Z, Erdogan F, Ullmann R, Novotná D, Spiegel M, et al. Two independent chromosomal rearrangements, a very small (550 kb) duplication of the 7q subtelomeric region and an atypical 17q11.2 (NF1) microdeletion, in a girl with neurofibromatosis. Cytogenet Genome Res. 2007;119(1–2):158–64.View ArticlePubMedGoogle Scholar
- Williams CA, Beaudet AL, Clayton-Smith J, Knoll JH, Kyllerman M, Laan LA, et al. Angelman syndrome 2005: updated consensus for diagnostic criteria. Am J Med Genet A. 2006;140:413–8.View ArticlePubMedGoogle Scholar
- Ranganath P, Agarwal M, Phadke SR. Angelman syndrome and prenatally diagnosed Prader-Willi syndrome in first cousins. Am J Med Genet A. 2011;155A:2788–90.View ArticlePubMedGoogle Scholar
- Smeets DF, Hamel BC, Nelen MR, Smeets HJ, Bollen JH, Smits AP, et al. Prader-Willi syndrome and Angelman syndrome in cousins from a family with a translocation between chromosomes 6 and 15. N Engl J Med. 1992;326:807–11.View ArticlePubMedGoogle Scholar
- Ye Y, Qian Y, Xu C, Jin F. Meiotic segregation analysis of embryos from reciprocal translocation carriers in PGD cycles. Reprod Biomed Online. 2012;24:83–90.View ArticlePubMedGoogle Scholar
- Yilmaz A, Zhang XY, Chung JT, Tan SL, Holzer H, Ao A. Chromosome segregation analysis in human embryos obtained from couples involving male carriers of reciprocal or Robertsonian translocation. PLoS One. 2012;7:e46046.View ArticlePubMed CentralPubMedGoogle Scholar
- Van Buggenhout G, Fryns JP. Angelman syndrome (AS, MIM 105830). Eur J Hum Genet. 2009;17:1367–73.View ArticlePubMed CentralPubMedGoogle Scholar
- Yatsenko SA, Kruer MC, Bader PI, Corzo D, Schuette J, Keegan CE, et al. Identification of critical regions for clinical features of distal 10q deletion syndrome. Clin Genet. 2009;76:54–62.View ArticlePubMedGoogle Scholar
- Davies J, Jaffé A, Bush A. Distal 10q trisomy syndrome with unusual cardiac and pulmonary abnormalities. J Med Genet. 1998;35(1):72–4.View ArticlePubMed CentralPubMedGoogle Scholar
- Flori E, Biancalana V, Girard-Lemaire F, Favre R, Flori J, Doray B, et al. Difficulties of genetic counseling and prenatal diagnosis in a consanguineous couple segregating for the same translocation (14;15) (q11;q13) and at risk for Prader-Willi and Angelman syndromes. Eur J Hum Genet. 2004;12:181–6.View ArticlePubMedGoogle Scholar
- Michelson M, Eden A, Vinkler C, Leshinsky-Silver E, Kremer U, Lerman-Sagie T, et al. Familial partial trisomy 15q11-13 presenting as intractable epilepsy in the child and schizophrenia in the mother. Eur J Paediatr Neurol. 2011;15(3):230–3.View ArticlePubMedGoogle Scholar
- Battaglia A. The inv dup(15) or idic(15) syndrome: a clinically recognisable neurogenetic disorder. Brain Dev. 2005;27:365–9.View ArticlePubMedGoogle Scholar
- Battaglia A. The inv dup (15) or idic (15) syndrome (Tetrasomy 15q). Orphanet J Rare Dis. 2008;3:30.View ArticlePubMed CentralPubMedGoogle Scholar
- Battaglia A, Parrini B, Tancredi R. The behavioral phenotype of the idic(15) syndrome. Am J Med Genet C Semin Med Genet. 2010;154C:448–55.View ArticlePubMedGoogle Scholar
- Marini C, Cecconi A, Contini E, Pantaleo M, Metitieri T, Guarducci S, et al. Clinical and genetic study of a family with a paternally inherited 15q11-q13 duplication. Am J Med Genet A. 2013;161A(6):1459–64.View ArticlePubMedGoogle Scholar
- Urraca N, Cleary J, Brewer V, Pivnick EK, McVicar K, Thibert RL, et al. The interstitial duplication 15q11.2-q13 syndrome includes autism, mild facial anomalies and a characteristic EEG signature. Autism Res. 2013;6:268–79.View ArticlePubMed CentralPubMedGoogle Scholar
- Doornbos M, Sikkema-Raddatz B, Ruijvenkamp CA, Dijkhuizen T, Bijlsma EK, Gijsbers AC, et al. Nine patients with a microdeletion 15q11.2 between breakpoints 1 and 2 of the Prader-Willi critical region, possibly associated with behavioural disturbances. Eur J Med Genet. 2009;52:108–15.View ArticlePubMedGoogle Scholar
- Sempere Perez A, Manchon Trives I, Palazon Azorin I, Alcaraz Mas L, Perez Lledo E, Galan Sanchez F. 15Q11.2 (BP1-BP2) microdeletion, a new syndrome with variable expressivity. An Pediatr (Barc). 2011;75:58–62.View ArticleGoogle Scholar
- Burnside RD, Pasion R, Mikhail FM, Carroll AJ, Robin NH, Youngs EL, et al. Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay. Hum Genet. 2011;130:517–28.View ArticlePubMedGoogle Scholar
- Wong D, Johnson SM, Young D, Iwamoto L, Sood S, Slavin TP. Expanding the BP1-BP2 15q11.2 Microdeletion Phenotype: Tracheoesophageal Fistula and Congenital Cataracts. Case Rep Genet. 2013;2013:801094.PubMed CentralPubMedGoogle Scholar
- Faletra F, D'Adamo AP, Santa Rocca M, Carrozzi M, Perrone MD, Pecile V, et al. Does the 1.5 Mb microduplication in chromosome band Xp22.31 have a pathogenetic role? New contribution and a review of the literature. Am J Med Genet A. 2012;158A:461–4.View ArticlePubMedGoogle Scholar
- Li F, Shen Y, Kohler U, Sharkey FH, Menon D, Coulleaux L, et al. Interstitial microduplication of Xp22.31: Causative of intellectual disability or benign copy number variant? Eur J Med Genet. 2010;53:93–9.View ArticlePubMedGoogle Scholar
- Liu P, Erez A, Nagamani SC, Bi W, Carvalho CM, Simmons AD, et al. Copy number gain at Xp22.31 includes complex duplication rearrangements and recurrent triplications. Hum Mol Genet. 2011;20:1975–88.View ArticlePubMed CentralPubMedGoogle Scholar
- Hickey SE, Thrush DL, Walters-Sen L, Reshmi SC, Astbury C, Gastier-Foster JM, et al. A case of an atypically large proximal 15q deletion as cause for Prader-Willi syndrome arising from a de novo unbalanced translocation. Eur J Med Genet. 2013;56:510–4.View ArticlePubMedGoogle Scholar
- Horsthemke B, Maat-Kievit A, Sleegers E, van den Ouweland A, Buiting K, Lich C, et al. Familial translocations involving 15q11-q13 can give rise to interstitial deletions causing Prader-Willi or Angelman syndrome. J Med Genet. 1996;33:848–51.View ArticlePubMed CentralPubMedGoogle Scholar
- Klein OD, Cotter PD, Albertson DG, Pinkel D, Tidyman WE, Moore MW, et al. Prader-Willi syndrome resulting from an unbalanced translocation: characterization by array comparative genomic hybridization. Clin Genet. 2004;65:477–82.View ArticlePubMedGoogle Scholar
- Kosaki R, Migita O, Takahashi T, Kosaki K. Two distinctive classic genetic syndromes, 22q11.2 deletion syndrome and Angelman syndrome, occurring within the same family. Am J Med Genet A. 2009;149A:702–5.View ArticlePubMedGoogle Scholar
- Krajewska Walasek M, Gutkowska A, Bielinska B, Goryluk-Kozakiewicz B, Popowska E. A case of Prader-Willi syndrome arising as a result of familial unbalanced translocation t(11;15)(q25;q13). Clin Genet. 1998;54:60–4.View ArticlePubMedGoogle Scholar
- Toth-Fejel S, Olson S, Gunter K, Quan F, Wolford J, Popovich BW, et al. The impact of imprinting: Prader-Willi syndrome resulting from chromosome translocation, recombination, and nondisjunction. Am J Hum Genet. 1996;58:1008–16.PubMed CentralPubMedGoogle Scholar
- Varela MC, Lopes GM, Koiffmann CP. Prader-Willi syndrome with an unusually large 15q deletion due to an unbalanced translocation t(4;15). Ann Genet. 2004;47:267–73.View ArticlePubMedGoogle Scholar
- Liehr T, Cirkovic S, Lalic T, Guc-Scekic M, de Almeida C, Weimer J, et al. Complex small supernumerary marker chromosomes – an update. Mol Cytogenet. 2013;6:46.View ArticlePubMed CentralPubMedGoogle Scholar
- Ramsden SC, Clayton-Smith J, Birch R, Buiting K. Practice guidelines for the molecular analysis of Prader-Willi and Angelman syndromes. BMC Med Genet. 2010;11:70.View ArticlePubMed CentralPubMedGoogle Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.